Association of mast cell, eosinophil leucocyte and microvessel densities in actinic cheilitis and lip squamous cell carcinoma

Histopathology

Volumn 57, Issue 6, 2010, Pages 796-805

  Souza, Ludmilla R ^a   Fonseca Silva, Thiago ^a   Santos, Carolina C O ^a   Oliveira, Marcos V M ^a   Corrêa Oliveira, Rodrigo ^b   Guimarães, André L S ^a   De Paula, Alfredo M B ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Actinic cheilitis; Eosinophil leucocyte; Histochemistry; Immunohistochemistry; Lip carcinogenesis; Lip squamous cell carcinoma; Mast cell; Microvessel density

Indexed keywords

TUMOR MARKER;

ACTINIC CHEILITIS; ADULT; ANGIOGENESIS; ARTICLE; CANCER RISK; CELL DENSITY; CELL FUNCTION; CHEILITIS; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LIP TUMOR; MAJOR CLINICAL STUDY; MALE; MAST CELL; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEILITIS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIP NEOPLASMS; MALE; MAST CELLS; MICROVESSELS; MIDDLE AGED; MOUTH MUCOSA; NEOVASCULARIZATION, PATHOLOGIC;

EID: 78650232883     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03721.x     Document Type: Article

References (66)

1. Marrot L, Meunier JR. Skin DNA photodamage and its biological consequences. J. Am. Acad. Dermatol. 2008; 58; S139-S148.
2. Gallagher RP, Lee TK. Adverse effects of ultraviolet radiation: a brief review. Prog. Biophys. Mol. Biol. 2006; 92; 119-131.
3. Cavalcante ASR, Anbinder AL, Carvalho YR. Actinic cheilitis: clinical and histological features. J. Oral Maxillofacial Surg. 2008; 66; 498-503.
4. Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis. 1999; 5; 185-195.
5. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420; 860-867.
6. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol. Cell Biol. 2001; 79; 547-568.
7. Norval M. The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog. Biophys. Mol. Biol. 2006; 92; 108-118.
8. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407; 249-257.
9. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971; 285; 1182-1186.
10. Fox SB. Tumour angiogenesis and prognosis. Histopathology 1997; 30; 294-301.
11. Raica M, Cimpean AM, Ribatti D. Angiogenesis in pre-malignant conditions. Eur. J. Cancer 2009; 45; 1924-1934.
12. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324; 1-8.
13. Weidner N. The importance of tumor angiogenesis: the evidence continues to grow. Am. J. Clin. Pathol. 2004; 122; 675-677.
14. Abbas NF, El-Sharkawy SL, Abbas EA, Abdel ME-S. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007; 103; 385-390.
15. Hannen EJ, Riediger D. The quantification of angiogenesis in relation to metastasis in oral cancer: a review. Int. J. Oral Maxillofac. Surg. 2004; 33; 2-7.
16. Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol. 1997; 33; 369-374.
17. Murray JD, Carlson GW, McLaughlin K et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer. Am. J. Surg. 1997; 174; 523-526.
18. Pazouki S, Chisholm DM, Adi MM et al. The association between tumour progression and vascularity in the oral mucosa. J. Pathol. 1997; 183; 39-43.
19. Ravi D, Ramadas K, Mathew BS, Nalinakumari KR, Nair MK, Pillai MR. Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol. 1998; 34; 543-548.
20. Rubio L, Burgos JS, Lopez-Guerrero JA, Morera C, Vera-Sempere FJ. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol. Res. Pract. 2002; 198; 97-102.
21. Kyzas D, Stefanou NJ, Agnantis PA. Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol. 2004; 40; 141-947.
22. Tahan SR, Stein AL. Angiogenesis in invasive squamous cell carcinoma of the lip: tumor vascularity is not an indicator of metastatic risk. J. Cutan. Pathol. 2006; 22; 236-240.
23. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008; 8; 618-631.
24. Kondoh N, Ohkura S, Arai M et al. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma. Oral Oncol. 2007; 43; 455-462.
25. Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J. Dermatol. Sci. 2008; 49; 7-19.
26. Gurish MF, Boyce JA. Mast cell growth, differentiation, and death. Clin. Rev. Allergy Immunol. 2002; 22; 107-118.
27. Costa NL, Oton-Leite AF, Cheim-Junior AP et al. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis. Histol. Histopathol. 2009; 24; 457-465.
28. Galinsky DS, Nechushtan H. Mast cells and cancer - no longer just basic science. Crit. Rev. Oncol. Hematol. 2008; 68; 115-130.
29. Hartveit F, Thoresen S, Tangen M, Maartmann-Moe H. Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis 1984; 4; 146-155.
30. Rojas IG, Spencer ML, Martinez A, Maurelia MA, Rudolph MI. Characterization of mast cell subpopulations in lip cancer. J. Oral Pathol. Med. 2005; 34; 268-273.
31. Hiromatsu Y, Toda S. Mast cells and angiogenesis. Microsc. Res. Tech. 2003; 60; 64-69.
32. Kessler DA, Langer RS, Pless NA, Folkman J. Mast cells and tumor angiogenesis. Int. J. Cancer 1976; 18; 703-709.
33. Gleich GJ, Loegering DA. Immunobiology of eosinophils. Annu. Rev. Immunol. 1984; 2; 429-459.
34. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004; 59; 268-275.
35. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am. J. Respir. Cell Mol. Biol. 1997; 17; 70-77.
36. Solomon A, Aloe L, Pe'er J et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J. Allergy Clin. Immunol. 1998; 102; 454-460.
37. Stahle-Backdahl M, Parks WC. 92-kd Gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol. 1993; 142; 995-1000.
38. Lowe D, Jorizzo J, Hutt MS. Tumour-associated eosinophilia: a review. J. Clin. Pathol. 1981; 34; 1343-1348.
39. Deron P, Goossens A, Halama AR. Tumour-associated tissue eosinophilia in head and neck squamous-cell carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 1996; 58; 167-170.
40. Dorta RG, Landman G, Kowalski LP, Lauris JR, Latorre MR, Oliveira DT. Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 2002; 41; 152-157.
41. Goldsmith MM, Cresson DH, Askin FB. The prognostic significance of stromal eosinophilia in head and neck cancer. Otolaryngol. Head Neck Surg. 1987; 96; 319-324.
42. Goldsmith MM, Belchis DA, Cresson DH, Merritt WD, Askin FB. The importance of the eosinophil in head and neck cancer. Otolaryngol. Head Neck Surg. 1992; 106; 27-33.
43. Sobin LH. TNM: evolution and relation to other prognostic factors. Semin. Surg. Oncol. 2003; 21; 3-7.
44. Pindborg JJ, Reichart PA, Smith CJ. International typing of cancer and precancer of the oral mucosa, 2nd edn. Berlin: Springer-Verlag, 1997.
45. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006; 42; 987-993.
46. de Oliveira MV, de Carvalho Fraga CA, Gomez RS, Paula AM. Immunohistochemical expression of interleukin-4, -6, -8, and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma. Head Neck 2009; 31; 1439-1446.
47. Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br. J. Cancer 2002; 86; 1444-1448.
48. Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin. Cancer Biol. 2007; 17; 275-287.
49. Lowe D, Fletcher CD. Eosinophilia in squamous cell carcinoma of the oral cavity, external genitalia and anus - clinical correlations. Histopathology 1984; 8; 627-632.
50. Tepper RI. The eosinophil-mediated antitumor activity of interleukin-4. J. Allergy Clin. Immunol. 1994; 94; 1225-1231.
51. Said M, Wiseman S, Yang J et al. Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms. BMC Clin. Pathol. 2005; 5; 1-8.
52. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004; 25; 235-241.
53. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004; 4; 540-550.
54. Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine 2008; 43; 374-379.
55. Pries R, Wollenberg B. Cytokines in head and neck cancer. Cytokine Growth Factor Rev. 2006; 17; 141-146.
56. Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 2003; 32; 195-199.
57. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79; 958-963.
58. Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann. Thorac. Surg. 2000; 69; 1686-1690.
59. Arora S, Kaur J, Sharma C et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin. Cancer Res. 2005; 11; 2272-2284.
60. Shieh YS, Lee HS, Shiah SG, Chu YW, Wu CW, Chang LC. Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J. Oral Pathol. Med. 2004; 33; 601-606.
61. Crivellato E, Nico B, Ribatti D. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett. 2008; 269; 1-6.
62. Coussens LM, Raymond WW, Bergers G et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999; 13; 1382-1397.
63. Yousefi S, Hemmann S, Weber M et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J. Immunol. 1995; 154; 5481-5490.
64. Falconieri G, Luna MA, Pizzolitto S, DeMaglio G, Angione V, Rocco M. Eosinophil-rich squamous carcinoma of the oral cavity: a study of 13 cases and delineation of a possible new microscopic entity. Ann. Diagn. Pathol. 2008; 12; 322-327.
65. Ghiabi M, Gallagher GT, Wong DT. Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor alpha in hamster oral carcinogenesis. Cancer Res. 1992; 52; 389-393.
66. Oliveira-Neto HH, Leite AF, Costa NL et al. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells. Oral Oncol. 2007; 43; 484-490.